Contexium

Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional

Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional is a published development and funding opportunity on Contexium. The donor or funder is Food and Drug Administration. Project location(s): United States. Applications close on 20 Aug 2026. Budget: 1,100,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.

Opportunity overview

Project name
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional
Food and Drug Administration logo
Food and Drug Administration
Donor
Food and Drug Administration

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States
Budget
1,100,000
Currency
US Dollar

Summary

The purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health...

Frequently asked questions

What is Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional?

Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional is a published development and funding opportunity on Contexium. The donor or funder is Food and Drug Administration. Project location(s): United States. Applications close on 20 Aug 2026. Budget: 1,100,000 USD. The purpose of this Notice of Funding Opportunity (NOFO) is to address topics related to the use of digital health technologies (DHTs) for remote data acquisition in clinical investigations to support drug development.

Who is funding Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional?

Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional is funded by Food and Drug Administration.

When is the deadline to apply for Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional?

The application deadline is 20 Aug 2026 00:00 (UTC).

Where will the Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional project take place?

The project location(s) are: United States.

What is the budget for Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional?

The available budget is 1,100,000 USD.

How can I apply for Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.